Business / Finance RSS Feed - Business / Finance

Curasan reveal plan for orthopedic product campaign

Curasan reveal plan for orthopedic product campaign

Curasan AG, a leading specialist for medical products in the field of orthobiologics, has received the market clearance of the Food and Drug Administration (FDA) and thus the authorization to market its synthetic bone regeneration material CERASORB Ortho FOAM in the United States. [More]
Pittcon announce speaker for Wallace H Coulter lecture

Pittcon announce speaker for Wallace H Coulter lecture

The Pittcon Program Committee is extremely pleased to announce that Dr. Karl Deisseroth, the D.H. Chen Professor of Bioengineering and of Psychiatry and Behavioral Sciences at Stanford University, and Investigator of the Howard Hughes Medical Institute, will deliver the Wallace H. Coulter lecture at Pittcon 2017. [More]
Bedfont Scientific signs OEM deal with Laborie for Gastrolyzer range of breath monitors

Bedfont Scientific signs OEM deal with Laborie for Gastrolyzer range of breath monitors

Laborie, an international leader in medical devices but notably gastroenterology, has signed an OEM agreement with Bedfont Scientific for their Gastrolyzer range of hydrogen and methane breath monitors. [More]

Bedfont Scientific appoints Jason Smith as new Managing Director

Bedfont Scientific Ltd, based in Harrietsham, gathered together its customers, distributors and partners in celebration of 40 years trading, where Trevor Smith announced that Bedfont was becoming a 2nd generation family company by appointing his son, Jason Smith, as the new Managing Director, with Trevor moving on to the position of Chairman. [More]

Bedfont Scientific successfully passes first unexpected BSI audit

Bedfont Scientific, based in Harrietsham, Kent, is a medical device manufacturer that specialises in breath analysis devices which are used to help detect certain health conditions. [More]

UL acquires Safeware Quasar to expand regulatory compliance and supply chain solutions

UL, a global safety science leader, today announced the acquisition of Safeware Quasar, a market leader in chemical regulatory compliance software and consultancy solutions, to expand UL’s supply chain data management and global regulatory compliance expertise. [More]
WideCells signs LOI with Qigenix to undertake research at Manchester stem cell facility

WideCells signs LOI with Qigenix to undertake research at Manchester stem cell facility

WideCells Group PLC, the healthcare services company focused on providing stem cell banking services and ground breaking insurance for stem cell treatment, is pleased to announce that it has taken steps to secure a new revenue stream, in addition to the cash flow opportunities outlined in the Company’s prospectus published in July this year, having signed a Letter of Intent (‘LOI’) with Qigenix and its CEO, Dr. Todd Ovokaitys. [More]
Integrated Technologies Ltd show potential for new opportunities through accreditation

Integrated Technologies Ltd show potential for new opportunities through accreditation

Integrated Technologies Ltd has successfully achieved accreditation of ITL Virginia Inc., its wholly owned subsidiary in the United States, to ISO 13485. [More]
Opportunity for Bibby Scientific to improve services in the EMEA market

Opportunity for Bibby Scientific to improve services in the EMEA market

Bibby Scientific Ltd announced that it will be taking over the distribution of Argos Technologies products, outside of the USA and Asia Pacific, from December 2016. As Bibby Scientific and Argos Technologies are now both part of the Cole-Parmer group, this gives the company an opportunity to streamline customer experience in the EMEA market. [More]
BioCision reveal new company focussing on clinical technology development

BioCision reveal new company focussing on clinical technology development

BioCision, LLC, a life science research and development company that standardizes basic laboratory processes, today announced the formation of MedCision, Inc., an independent company focused on automation of pre-clinical and clinical processes. [More]
MEDICA and COMPAMED 2016 offer excellent platform for global business relationships in medical technology industry

MEDICA and COMPAMED 2016 offer excellent platform for global business relationships in medical technology industry

Once again, the world’s biggest medical trade fair MEDICA and the leading international supplier trade fair COMPAMED, which take place in Düsseldorf, have provided a powerful stimulus for the international medical technology industry. [More]
RSM announces appointment of Helen Gordon as new Chief Executive

RSM announces appointment of Helen Gordon as new Chief Executive

The Royal Society of Medicine has today announced the appointment of Helen Gordon as Chief Executive. Ms Gordon joins the RSM from the Royal Pharmaceutical Society where she has held the position of Chief Executive since 2010. [More]
De-risking drug development free webinar from Envigo

De-risking drug development free webinar from Envigo

De-risking represents a relatively new but developing strategy designed to quickly assess if a new drug has a liability. Knowing your compound’s risk for drug-to-drug interactions (DDI), drug induced liver injury (DILI) and metabolites in safety testing (MIST) early on in drug development, leads to greater confidence and added value on your molecule’s journey to market. [More]

Mapi, Saama Technologies team up to strengthen analytics enabled business outcomes for customers

Mapi, the market leader in Prospective Real-World Evidence generation, Health Research Analytics and Evidence Synthesis announces their collaboration with Saama Technologies, Inc., the leading Big Data solutions company. [More]
Agendia partners with Cryogene and Mist to distribute breast cancer recurrence assay in the Middle East

Agendia partners with Cryogene and Mist to distribute breast cancer recurrence assay in the Middle East

Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announced today a partnership agreement to distribute the company’s breast cancer recurrence assay, MammaPrint, in the Middle East. [More]
Alesi Surgical announces entry into lucrative trocar market

Alesi Surgical announces entry into lucrative trocar market

Alesi Surgical Limited, the advanced minimally invasive surgery medical device manufacturer, has announced its entry into the lucrative trocar market estimated to be worth $800 million per year, globally. [More]
Braintrain 20:20 receives significant seed investment for new sleep aid device

Braintrain 20:20 receives significant seed investment for new sleep aid device

An award-winning consumer personalised health device manufacturer specialising in sleep aid technologies is gearing up for growth following significant seed investment. [More]
Domain Therapeutics and Medicxi partner to launch Mavalon Therapeutics

Domain Therapeutics and Medicxi partner to launch Mavalon Therapeutics

Domain Therapeutics, a biopharmaceutical company that specializes in the discovery and development of G protein-coupled receptor (GPCR) drugs, today announces the creation of Mavalon Therapeutics, a company focused on stopping the progression of Parkinson’s disease. [More]
AXT named first Nanolive’s Distributor of the Year

AXT named first Nanolive’s Distributor of the Year

AXT is very proud to have been named Nanolive’s Distributor of the Year in the first year since the 3D Cell Explorer was released. [More]
Fortimedix Surgical completes €11M funding round to support launch of world’s first single-port surgery solution

Fortimedix Surgical completes €11M funding round to support launch of world’s first single-port surgery solution

Fortimedix Surgical today announced the completion of an €11M Series A funding round. [More]
Advertisement
Advertisement